Target Hgb for Epogen therapy is?

Study for the DaVita Peritoneal Dialysis (PD) Exam. Utilize flashcards and multiple choice questions, each question has detailed explanations. Prepare thoroughly for your exam!

Multiple Choice

Target Hgb for Epogen therapy is?

Explanation:
The aim of Epogen (epoetin alfa) therapy is to improve anemia without overcorrecting, prioritizing safety. Pushing hemoglobin above about 11 g/dL in dialysis patients has been linked to higher risk of cardiovascular events, hypertension, stroke, and thrombosis, and it often doesn’t provide additional symptomatic benefit. So the safest and most effective target is a hemoglobin of 11 g/dL or less. When Hb is below that threshold, the epoetin dose can be adjusted upward carefully; if Hb approaches or exceeds 11 g/dL, the dose should be reduced or held and Hb rechecked after a short interval. Maintaining adequate iron stores is also important for ESA response, since iron deficiency can blunt the effect of Epogen and may necessitate iron supplementation.

The aim of Epogen (epoetin alfa) therapy is to improve anemia without overcorrecting, prioritizing safety. Pushing hemoglobin above about 11 g/dL in dialysis patients has been linked to higher risk of cardiovascular events, hypertension, stroke, and thrombosis, and it often doesn’t provide additional symptomatic benefit. So the safest and most effective target is a hemoglobin of 11 g/dL or less. When Hb is below that threshold, the epoetin dose can be adjusted upward carefully; if Hb approaches or exceeds 11 g/dL, the dose should be reduced or held and Hb rechecked after a short interval. Maintaining adequate iron stores is also important for ESA response, since iron deficiency can blunt the effect of Epogen and may necessitate iron supplementation.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy